Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 19 with Dr. Samuel Ludwin on treating MS subtypes
Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Neuroprotective effects of resident microglia following acute brain injury.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.
Interleukin-1beta promotes repair of the CNS.
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
Multiple sclerosis: pathogenesis and treatment.
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Relationship between disease-modifying therapy and depression in multiple sclerosis.
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
[Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Firategrast
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.
Episode 16 with Dr. Revere [double-quote]Rip[double-quote] Kinkel on how to improve patient outreach
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.

Pages